Last Price
0.53
Today's Change
+0.026 (5.15%)
Day's Change
0.505 - 0.53
Trading Volume
39,028
Market Cap
2 Million
Shares Outstanding
4 Million
Avg Volume
535,236
Avg Price (50 Days)
0.63
Avg Price (200 Days)
1.87
PE Ratio
-0.01
EPS
-74.61
Earnings Announcement
25-Mar-2025
Previous Close
0.50
Open
0.52
Day's Range
0.5046 - 0.5299
Year Range
0.36 - 9.1
Trading Volume
512,259
1 Day Change
5.12%
5 Day Change
-5.39%
1 Month Change
-26.38%
3 Month Change
-28.39%
6 Month Change
-75.24%
Ytd Change
-92.22%
1 Year Change
-93.43%
3 Year Change
-99.90%
5 Year Change
-99.93%
10 Year Change
-100.00%
Max Change
-100.00%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.